J. Domenech

1.0k total citations
28 papers, 799 citations indexed

About

J. Domenech is a scholar working on Pharmaceutical Science, Dermatology and Molecular Biology. According to data from OpenAlex, J. Domenech has authored 28 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmaceutical Science, 9 papers in Dermatology and 5 papers in Molecular Biology. Recurrent topics in J. Domenech's work include Advancements in Transdermal Drug Delivery (14 papers), Dermatology and Skin Diseases (9 papers) and Advanced Drug Delivery Systems (6 papers). J. Domenech is often cited by papers focused on Advancements in Transdermal Drug Delivery (14 papers), Dermatology and Skin Diseases (9 papers) and Advanced Drug Delivery Systems (6 papers). J. Domenech collaborates with scholars based in Spain, United Kingdom and United States. J. Domenech's co-authors include R. Obach, Elvira Escribano, Ana Cristina Calpena, J. Cordero, Nicholas A. Peppas, Josep Queralt, Helena Colom, J.M. Moreno, C. Peraire and Mercedes Camacho and has published in prestigious journals such as Angewandte Chemie International Edition, ACS Catalysis and Antimicrobial Agents and Chemotherapy.

In The Last Decade

J. Domenech

24 papers receiving 753 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Domenech Spain 13 515 200 115 111 70 28 799
Ebtessam A. Essa Egypt 18 584 1.1× 128 0.6× 147 1.3× 81 0.7× 30 0.4× 43 893
Gamal M. Mahrous Saudi Arabia 14 543 1.1× 59 0.3× 121 1.1× 68 0.6× 58 0.8× 44 790
Çetin Taş Türkiye 14 499 1.0× 104 0.5× 107 0.9× 54 0.5× 31 0.4× 29 681
Alia Badawi Egypt 16 536 1.0× 115 0.6× 141 1.2× 70 0.6× 24 0.3× 41 802
Vikas Bali India 14 571 1.1× 90 0.5× 155 1.3× 87 0.8× 29 0.4× 18 856
Rosa Pireddu Italy 15 372 0.7× 137 0.7× 104 0.9× 49 0.4× 29 0.4× 24 630
Yun-Seok Rhee South Korea 20 660 1.3× 78 0.4× 102 0.9× 70 0.6× 50 0.7× 61 1.0k
Javad Shokri Iran 17 532 1.0× 195 1.0× 85 0.7× 84 0.8× 30 0.4× 51 951
Mikolaj Milewski United States 13 707 1.4× 352 1.8× 126 1.1× 53 0.5× 31 0.4× 22 877
Hanan M. El-Laithy Egypt 16 685 1.3× 104 0.5× 222 1.9× 129 1.2× 35 0.5× 25 982

Countries citing papers authored by J. Domenech

Since Specialization
Citations

This map shows the geographic impact of J. Domenech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Domenech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Domenech more than expected).

Fields of papers citing papers by J. Domenech

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Domenech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Domenech. The network helps show where J. Domenech may publish in the future.

Co-authorship network of co-authors of J. Domenech

This figure shows the co-authorship network connecting the top 25 collaborators of J. Domenech. A scholar is included among the top collaborators of J. Domenech based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Domenech. J. Domenech is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Domenech, J., et al.. (2025). Reductive aminases discovered from bacteria to synthesize chiral amines. New Biotechnology. 85. 175–175.
2.
Zhao, Fei, J. Domenech, Murray J. B. Brown, et al.. (2025). Engineered Biocatalyst for Enantioselective Hydrazone Reduction. Angewandte Chemie International Edition. 64(26). e202424350–e202424350.
3.
Domenech, J., et al.. (2024). Discovery and Synthetic Applications of a NAD(P)H-Dependent Reductive Aminase from Rhodococcus erythropolis. ACS Catalysis. 15(1). 211–219. 2 indexed citations
4.
Domenech, J., et al.. (2014). An improved cryopreservation method for porcine buccal mucosa in ex vivo drug permeation studies using Franz diffusion cells. European Journal of Pharmaceutical Sciences. 60. 49–54. 42 indexed citations
5.
Calpena, Ana Cristina, et al.. (2014). A comparative ex vivo drug permeation study of beta-blockers through porcine buccal mucosa. International Journal of Pharmaceutics. 468(1-2). 50–54. 13 indexed citations
6.
Gautier, J., et al.. (2014). Efficacy and Hemotoxicity of Stealth Doxorubicin-Loaded Magnetic Nanovectors on Breast Cancer Xenografts. Journal of Biomedical Nanotechnology. 11(1). 177–189. 13 indexed citations
7.
Colom, Helena, et al.. (2011). Transdermal delivery of alprazolam from a monolithic patch: formulation based onin vitrocharacterization. Drug Development and Industrial Pharmacy. 38(10). 1171–1178. 11 indexed citations
8.
Escribano, Elvira, et al.. (2005). Rapid Human Skin Permeation and Topical Anaesthetic Activity of a New Amethocaine Microemulsion. Skin Pharmacology and Physiology. 18(6). 294–300. 12 indexed citations
9.
Domenech, J., et al.. (2005). Design of poly(ethylene glycol)-tethered copolymers as novel mucoadhesive drug delivery systems. European Journal of Pharmaceutics and Biopharmaceutics. 63(1). 11–18. 100 indexed citations
10.
Peraire, C., et al.. (2005). Estimation of Transdermal Permeation Parameters in Non-stationary Diffusion Experiments. Application to Pre-treatment Studies with Terpenes. Pharmaceutical Research. 22(1). 94–102. 6 indexed citations
11.
Escribano, Elvira, et al.. (2003). Assessment of diclofenac permeation with different formulations: anti-inflammatory study of a selected formula. European Journal of Pharmaceutical Sciences. 19(4). 203–210. 120 indexed citations
12.
Cordero, J., et al.. (2001). In vitro based index of topical anti-inflammatory activity to compare a series of NSAIDs. European Journal of Pharmaceutics and Biopharmaceutics. 51(2). 135–142. 65 indexed citations
13.
Colom, Helena, et al.. (1999). Absolute Bioavailability and Absorption Profile of Cyanamide in Man. Journal of Pharmacokinetics and Biopharmaceutics. 27(4). 421–436. 6 indexed citations
14.
Peraire, C., et al.. (1998). Influence of d-limonene on the transdermal penetration of felodipine. European Journal of Drug Metabolism and Pharmacokinetics. 23(1). 7–12. 11 indexed citations
15.
Cordero, J., et al.. (1997). A Comparative Study of the Transdermal Penetration of a Series of Nonsteroidal Antiinflammatory Drugs. Journal of Pharmaceutical Sciences. 86(4). 503–508. 157 indexed citations
16.
Calpena, Ana Cristina, et al.. (1994). A Comparative in Vitro Study of Transdermal Absorption of Antiemetics. Journal of Pharmaceutical Sciences. 83(1). 29–33. 33 indexed citations
17.
Calpena, Ana Cristina, et al.. (1994). Effect of d-limonene on the transdermal permeation of nifedipine and domperidone. International Journal of Pharmaceutics. 103(2). 179–186. 22 indexed citations
18.
Vila, Joaquim, Ana Cristina Calpena, R. Obach, & J. Domenech. (1992). Gastric, intestinal and colonic absorption of a series of beta-blockers in the rat.. PubMed. 30(8). 280–6. 2 indexed citations
19.
Colom, Helena, et al.. (1991). A Comparative In Vitro Study of Transdermal Absorption of a Series of Calcium Channel Antagonists. Journal of Pharmaceutical Sciences. 80(10). 931–934. 61 indexed citations
20.
Domenech, J., et al.. (1953). Sintomatología ocular de la acrodinia. 13(11). 1400–1400.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026